OTC · Medical - Pharmaceuticals

Quick-Med Technologies, Inc. (QMDT) Stock

$0.00 OTC: QMDT Healthcare

Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies.

Valuation

MetricValue
Price$0.00
Market Cap$29877
P/E Ratio-0.04
P/B Ratio0.00
P/S Ratio0.03
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE11.11%
ROA-35.21%
ROCE4.78%
Gross Margin13.80%
Operating Margin-77.01%
Net Margin-76.80%
Debt/Equity0.00
Current Ratio0.04

Annual Financials (USD)

Metric20082009201020112012
Revenue$1.0M$1.0M$1.0M$1.0M$1.0M
Operating Profit$-2.0M$-2.0M$-2.0M$-1.0M$0
Net Profit$-2.0M$-4.0M$-2.0M$-2.0M$-1.0M
EPS$-0.07$-0.11$-0.07$-0.05$-0.02
Op Margin-175.7%-209.8%-197.4%-124.1%-40.5%

Balance Sheet (USD)

Metric20082009201020112012
Total Assets$0$1.0M$2.0M$1.0M$1.0M
Total Liabilities$5.0M$8.0M$8.0M$9.0M$10.0M
Cash$0$1.0M$1.0M$0$0
Borrowings$4.0M$7.0M$0$0$0

Cash Flow (USD)

Metric20082009201020112012
Operating Cash Flow$-1.0M$-1.0M$-1.0M$-1.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$1.0M$0$-1.0M$0
Free Cash Flow$-1.0M$-1.0M$-1.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.02
FCF Yield-2.76%
Quick Ratio0.03
Interest Coverage-0.84
Return 1Y700.00%
Return 3Y60.00%
Return 5Y-98.22%

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANQFCanaQuest Medical Corp. $0.00 — 0.00 $2121 0.00%
CVHIFVentura Cannabis & Wellness Corporation $0.00 — 0.00 $3704 0.00%
DGENDeltagen Inc. $0.00 — 0.04 $3859 0.00%
EMGEEmergent Health Corp $0.00 — -0.02 $4193 0.00%
NMXSNet Medical Xpress Solutions, Inc. $0.00 — -0.01 $26367 0.00%

About Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The company’s core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials. In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products. Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.

Quick-Med Technologies, Inc. (QMDT) stock trades at $0.00 with a market capitalization of $29877. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.04, reflecting a net loss over the last twelve months, price-to-book of 0.00, price-to-sales of 0.03.

On profitability, Quick-Med Technologies, Inc. generates a return on equity (ROE) of 11.11%, return on capital employed of 4.78%, an operating margin of -77.01%, a net profit margin of -76.80%.

Official website: www.quickmedtech.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.